Kynam Capital Management, LP Amarin Corp Plcuk Transaction History
Kynam Capital Management, LP
- $1.58 Billion
- Q4 2024
A detailed history of Kynam Capital Management, LP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Kynam Capital Management, LP holds 12,414,628 shares of AMRN stock, worth $5.71 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
12,414,628
Previous 12,414,628
-0.0%
Holding current value
$5.71 Million
Previous $7.82 Million
23.81%
% of portfolio
0.38%
Previous 0.64%
Shares
9 transactions
Others Institutions Holding AMRN
# of Institutions
183Shares Held
71.2MCall Options Held
183KPut Options Held
66.7K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$11.4 Million3.7% of portfolio
-
Morgan Stanley New York, NY4.41MShares$2.03 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$1.15 Million1.0% of portfolio
-
Waterfront Wealth Inc.2.48MShares$1.14 Million0.31% of portfolio
-
Two Sigma Investments, LP New York, NY2.17MShares$999,9190.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $185M
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...